Importance of Regulations for Advertising Medicines and Medical Devices
Healthcare regulations safeguard public health by ensuring accurate information and ethical
marketing. They prevent misleading claims, promote responsible advertising, and require
scientific evidence for product claims. This empowers patients with reliable information and
protects them from misuse of medications. Regulations also ensure fair competition within the
industry.
1. Applicable Laws Regarding Advertising of Medicines and Medical Devices in the Netherlands
1.1 Medicines
- Medicines Act: The principal legislation governing the advertisement of
medicines. It outlines the rules for promoting medicinal products to ensure they are not
misleading and are safe for public consumption.
- Dutch Civil Code (Articles 6:194–196): Addresses misleading and comparative
advertising and applies to all types of advertising, including medicinal products.
1.2 Medical Devices
- Medical Devices Act: Governs medical devices but does not contain specific
advertising provisions. General advertising principles and self-regulatory codes apply.
- Dutch Civil Code: Ensures that advertising of medical devices is not misleading
or unfairly comparative.
2. Additional Legislative Frameworks and Self-Regulatory Codes of Conduct
2.1 Medicines
- Code of Conduct on Pharmaceutical Advertising (Code PA): Sets detailed
standards for ethical promotion and avoidance of misleading claims.
- Code for Advertising of Medicinal Products to the General Public (Code AGP):
Regulates advertising of non-prescription medicines to ensure clarity and truthfulness.
2.2 Medical Devices
- Code on Advertisement for Medical (Self-Care) Devices (Code AMD): Establishes
standards for advertising medical devices intended for consumer use without professional
intervention.
3. Licenses, Approvals, and Fees
3.1 General Public
- Medicines: Advertisements must have a valid authorization number from the
Inspection Board for the Public Promotion of Medicines (KOAG).
- Medical Devices: No specific licensing system exists; compliance with general
advertising standards is monitored.
3.2 Healthcare Professionals
There is no formal licensing system for advertisements directed at healthcare professionals.
Compliance with applicable laws and self-regulatory codes is expected.
4. Prescription-Only vs. Over-the-Counter Medicines
- Prescription-only Medicines: Cannot be advertised to the general public,
including medicines listed under the Opium Act.
- Over-the-Counter (OTC) Medicines: Classified as UA, UAD, and AV. Advertising is
permitted unless substances regulated under the Opium Act are included.
5. Restrictions on Advertising to the General Public
5.1 Medicines
-
Prescription-only and Opium Act-listed medicines cannot be advertised to the general public.
-
Advertisements must align with the Summary of Product Characteristics (SmPC) and packaging
information.
-
Promotional practices that do not promote rational use, such as free samples or conditional
sales, are prohibited.
5.2 Medical Devices
-
Devices must comply with the Medical Devices Act and be advertised in line with their
intended use.
-
Advertising must not be misleading regarding the device’s effects or usage.
6. Advertising to Healthcare Professionals
6.1 Medicines
-
Advertisements must accurately reflect authorized product information.
-
Misleading or deceptive advertising is prohibited.
-
Providing samples of substances listed under the Opium Act is not permitted.
6.2 Medical Devices
There is currently no specific legislation or code governing the advertisement of medical
devices to healthcare professionals.
7. Information Required in Advertisements Directed to Healthcare Professionals
7.1 Medicines
- Product name and marketing party
- Active ingredients and pharmaceutical group
- Therapeutic indications and adverse reactions
- Contraindications and prescription status
7.2 Medical Devices
No specific requirements apply, but advertisements must follow general advertising principles
and accurately represent the product.
8. Advertising Requirements
8.1 Medicines
- Product name and active substance
- Indications and contra-indications
- Encouragement to read the package leaflet
8.2 Medical Devices
- Product name and classification as a medical device
- Main uses and situations where usage is discouraged
- Instruction to read the provided user instructions
9. Scientific Data Requirements
-
Claims must align with authorized use and be supported by the latest scientific evidence.
-
Data must be accurate, verifiable, objective, and not misleading.
-
Exaggerated or unverifiable claims are prohibited.
10. Comparative Advertising Rules
Prescription-Only and Opium Act-Listed Medicines
Advertising must align with the government-approved SPC and promote rational use. Claims must
be accurate, up-to-date, truthful, and verifiable, supported by proper scientific references.
Medicines Advertised to the General Public
Advertisements must objectively present facts and avoid misleading or exaggerated claims. The
product must be clearly identified as a medicine and not equated with food, cosmetics, or other
consumer goods.
Medical Devices in Pharmaceutical Form
Advertising must provide an objective representation of facts, clearly identify the product as
a medical device, and avoid exaggerated claims. Products can only be advertised as “new” for up
to two years.
11. Internet and Social Media Advertising
The same rules that apply to offline advertising also apply online. Social media advertising
must comply with written and oral advertising standards and applies only to content accessible
in the Netherlands and aimed at a Dutch audience.
General Rules
- Advertising must always be recognizable as such
- The sender or responsible party must be identifiable
- The audience must be quantifiable
- Advertisers are responsible for linked or referenced content
12. Enforcement and Legal Consequences
Compliance with the Medicines Act is monitored by the Inspection for Health and Youth Care.
Sanctions for violations include:
- Administrative fines of up to €450,000
- Suspension or termination of product trade
- Withdrawal of products from the market
The Code Commission (CGR), Advertising Code Committee, and Board of Appeal assess compliance
with advertising codes and may impose reprimands, rectifications, recall orders, or publish
decisions publicly.
13. Future Developments in the Netherlands
There are currently no specific future developments noted regarding advertising regulations
for medicines and medical devices in the Netherlands.
How Can OMC Help?
- Professional review of marketing and advertising materials with reports
- Support in obtaining authority approvals where required
-
Professional translation services certified under ISO 17100